These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29785047)

  • 1. Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain.
    Sullivan JA; Stanek LM; Lukason MJ; Bu J; Osmond SR; Barry EA; O'Riordan CR; Shihabuddin LS; Cheng SH; Scaria A
    Gene Ther; 2018 Jun; 25(3):205-219. PubMed ID: 29785047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
    Woodard KT; Liang KJ; Bennett WC; Samulski RJ
    J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.
    Boye SL; Bennett A; Scalabrino ML; McCullough KT; Van Vliet K; Choudhury S; Ruan Q; Peterson J; Agbandje-McKenna M; Boye SE
    J Virol; 2016 Apr; 90(8):4215-4231. PubMed ID: 26865709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration.
    Mary B; Maurya S; Kumar M; Bammidi S; Kumar V; Jayandharan GR
    Mol Pharm; 2019 Nov; 16(11):4738-4750. PubMed ID: 31596095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Photoreceptor Transduction Efficacy of Capsid-Modified Adeno-Associated Viral Vectors Following Intravitreal and Subretinal Delivery in Sheep.
    Ross M; Obolensky A; Averbukh E; Ezra-Elia R; Yamin E; Honig H; Dvir H; Rosov A; Hauswirth WW; Gootwine E; Banin E; Ofri R
    Hum Gene Ther; 2020 Jul; 31(13-14):719-729. PubMed ID: 32486858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.
    Auricchio A; Kobinger G; Anand V; Hildinger M; O'Connor E; Maguire AM; Wilson JM; Bennett J
    Hum Mol Genet; 2001 Dec; 10(26):3075-81. PubMed ID: 11751689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.
    Yang GS; Schmidt M; Yan Z; Lindbloom JD; Harding TC; Donahue BA; Engelhardt JF; Kotin R; Davidson BL
    J Virol; 2002 Aug; 76(15):7651-60. PubMed ID: 12097579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology of a rationally-designed AAV2 capsid following intravitreal delivery in mice.
    Whitehead M; Sage A; Burgoyne T; Osborne A; Yu-Wai-Man P; Martin KR
    Gene Ther; 2023 Sep; 30(9):723-735. PubMed ID: 37386155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS.
    Naidoo J; Stanek LM; Ohno K; Trewman S; Samaranch L; Hadaczek P; O'Riordan C; Sullivan J; San Sebastian W; Bringas JR; Snieckus C; Mahmoodi A; Mahmoodi A; Forsayeth J; Bankiewicz KS; Shihabuddin LS
    Mol Ther; 2018 Oct; 26(10):2418-2430. PubMed ID: 30057240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.
    Kay CN; Ryals RC; Aslanidi GV; Min SH; Ruan Q; Sun J; Dyka FM; Kasuga D; Ayala AE; Van Vliet K; Agbandje-McKenna M; Hauswirth WW; Boye SL; Boye SE
    PLoS One; 2013; 8(4):e62097. PubMed ID: 23637972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea.
    Frederick A; Sullivan J; Liu L; Adamowicz M; Lukason M; Raymer J; Luo Z; Jin X; Rao KN; O'Riordan C
    Hum Gene Ther; 2020 Jul; 31(13-14):756-774. PubMed ID: 32578442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines.
    Ryals RC; Boye SL; Dinculescu A; Hauswirth WW; Boye SE
    Mol Vis; 2011 Apr; 17():1090-102. PubMed ID: 21552473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8.
    Khabou H; Desrosiers M; Winckler C; Fouquet S; Auregan G; Bemelmans AP; Sahel JA; Dalkara D
    Biotechnol Bioeng; 2016 Dec; 113(12):2712-2724. PubMed ID: 27259396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-translational modifications in capsid proteins of recombinant adeno-associated virus (AAV) 1-rh10 serotypes.
    Mary B; Maurya S; Arumugam S; Kumar V; Jayandharan GR
    FEBS J; 2019 Dec; 286(24):4964-4981. PubMed ID: 31330090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors.
    Reid CA; Ertel KJ; Lipinski DM
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6429-6439. PubMed ID: 29260200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
    Naumer M; Popa-Wagner R; Kleinschmidt JA
    J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants.
    Bennett A; Gargas J; Kansol A; Lewis J; Hsi J; Hull J; Mietzsch M; Tartaglia L; Muzyczka N; Bhattacharya N; Chipman P; Agbandje-McKenna M; McKenna R
    J Virol; 2023 Jul; 97(7):e0177222. PubMed ID: 37310260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.
    Shen X; Storm T; Kay MA
    Mol Ther; 2007 Nov; 15(11):1955-62. PubMed ID: 17726459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency.
    Tordo J; O'Leary C; Antunes ASLM; Palomar N; Aldrin-Kirk P; Basche M; Bennett A; D'Souza Z; Gleitz H; Godwin A; Holley RJ; Parker H; Liao AY; Rouse P; Youshani AS; Dridi L; Martins C; Levade T; Stacey KB; Davis DM; Dyer A; Clément N; Björklund T; Ali RR; Agbandje-McKenna M; Rahim AA; Pshezhetsky A; Waddington SN; Linden RM; Bigger BW; Henckaerts E
    Brain; 2018 Jul; 141(7):2014-2031. PubMed ID: 29788236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.